Sign In
Buy ZTS
$74.17
-1.16 (-1.54%)
At Close: Jul 22, 2026
Why Zoetis (ZTS) is a Top Value Stock for the Long-Term
10:41am, Wednesday, 18'th Feb 2026
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Mairs and Power's Strategic Moves: NVIDIA Corp Sees a -1.1% Portfolio Impact
06:12pm, Tuesday, 17'th Feb 2026
Exploring the Latest 13F Filing and Investment Strategies Mairs and Power (Trades, Portfolio) recently submitted their 13F filing for the fourth quarter of 202
Zoetis Inc. $ZTS Shares Sold by Crestwood Advisors Group LLC
05:05am, Tuesday, 17'th Feb 2026
Crestwood Advisors Group LLC reduced its position in shares of Zoetis Inc. (NYSE: ZTS) by 7.0% during the undefined quarter, according to the company in its most recent 13F filing with the Securities
Impax U.S. Sustainable Economy Fund Q4 2025 Contributors And Detractors
10:58am, Monday, 16'th Feb 2026
Eli Lilly is included due to its strategic positioning with respect to sustainability opportunities, specifically in HealthCare Access and Innovation. Advanced Micro Devices is owned for its exception
Zoetis: Why I'm Doubling Down On My Worst 2025 Pick
08:15am, Monday, 16'th Feb 2026
Zoetis is reiterated as a buy, with a 20% upside to a $159/share fair value, driven by margin expansion and a cheap valuation. ZTS delivered FY 2025 revenue of $9.5B, beating guidance, and presents ex
ABN Amro Investment Solutions Sells 6,170 Shares of Zoetis Inc. $ZTS
03:15am, Monday, 16'th Feb 2026
ABN Amro Investment Solutions lowered its holdings in shares of Zoetis Inc. (NYSE: ZTS) by 19.4% during the undefined quarter, according to its most recent Form 13F filing with the Securities and Exch
Zoetis Inc (ZTS) Q4 2025 Earnings Call Highlights: Strong Full-Year Growth Amid Competitive Pressures
04:05pm, Thursday, 12'th Feb 2026
Full-Year Revenue: $9.5 billion, 2% growth on a reported basis, 6% organic operational growth.Adjusted Net Income: $2.8 billion, 6% growth on a reported basis,
Analysts Question Zoetis' Pathway To Growth As Key Segments Slide
01:24pm, Thursday, 12'th Feb 2026
Animal health firm Zoetis Inc. (NYSE: ZTS) on Thursday reported a fourth-quarter 2025 adjusted earnings per share of $1.48. The company beat the consensus of $1.40.
Zoetis Inc. (ZTS) Q4 2025 Earnings Call Transcript
12:44pm, Thursday, 12'th Feb 2026
Zoetis Inc. (ZTS) Q4 2025 Earnings Call Transcript
Zoetis Stock Gains After Q4 Earnings & Revenues Beat Estimates
11:30am, Thursday, 12'th Feb 2026
ZTS stock rises after Q4 earnings and revenues top estimates, as strong international growth and upbeat 2026 guidance offset U.S. softness.
Zoetis (ZTS) Q4 Earnings: How Key Metrics Compare to Wall Street Estimates
10:31am, Thursday, 12'th Feb 2026
While the top- and bottom-line numbers for Zoetis (ZTS) give a sense of how the business performed in the quarter ended December 2025, it could be worth looking at how some of its key metrics compare
Zoetis (ZTS) Beats Q4 Earnings and Revenue Estimates
09:11am, Thursday, 12'th Feb 2026
Zoetis (ZTS) came out with quarterly earnings of $1.48 per share, beating the Zacks Consensus Estimate of $1.4 per share. This compares to earnings of $1.4 per share a year ago.
Zoetis forecasts strong 2026 profit, revenue on steady pet‑medicine demand
08:33am, Thursday, 12'th Feb 2026
Zoetis on Thursday forecast 2026 adjusted profit and revenue above Wall Street estimates, as demand across its companion-animal portfolio and resilient international markets helped offset softer trend
Zoetis Reports Fourth Quarter and Full Year 2025 Results
07:00am, Thursday, 12'th Feb 2026
PARSIPPANY, N.J.--(BUSINESS WIRE)---- $ZTS #animalhealth--Zoetis Inc. (NYSE: ZTS), the world's leading animal health company, today reported its financial results for the fourth quarter and full year
Top Wall Street Forecasters Revamp Zoetis Expectations Ahead Of Q4 Earnings
02:12am, Thursday, 12'th Feb 2026
Zoetis Inc. (NYSE: ZTS) will release earnings for its fourth quarter before the opening bell on Thursday, Feb. 12.
